NSN 6505-01-676-2174 · NIIN 016762174 · FSC 6505
NO DASHES 6505016762174
In Stock
PYRIDOSTIGMINE BROMIDE TABLETS
Drugs and Biologicals
Technical characteristics
11 rows
Straight from the federal item record. Entries the record leaves empty are shown empty — nothing is filled in on its behalf.
| MRC | Requirement | Value |
|---|---|---|
| SUPP | SUPPLEMENTARY FEATURES | STORE AT CONTROLLED ROOM TEMPERATURE 20 TO 25 DEGREES CELSIUS OR 68 TO 70 DEGREES FAHRENHEIT. |
| MDES | MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |
| CXCY | PART NAME ASSIGNED BY CONTROLLING AGENCY | PYRIDOSTIGMINE BROMIDE TABLETS,USP 30MG I.S. 210S PG |
| CSCX | TOTAL SECONDARY CONTAINER QUANTITY | 10 |
| CQCT | PRIMARY CONTAINER TYPE | PACKAGE |
| FEAT | SPECIAL FEATURES | 30MG ACTIVE INGREDIENT; INDIVIDUALLY SEALED, BLISTER OR STRIP PACKAGED; 10 PACKAGES OF 21 TABLETS (210 TABLETS PER PACKAGE); THE BLISTER OR STRIP PACKAGE IS CONTAINED INSIDE A CRUSH PROOF PLASTIC SLEEVE; FOR USE IN NERVE AGENT PRE-TREATMENT STORE AT CONTROLLED ROOM TEMPERATURE 20 TO 25 DEGREES CELSIUS OR 68 TO 70 DEGREES FAHRENHEIT. THIS ITEM IS NON-PROCURABLE. |
| CRXL | PRIMARY CONTAINER QUANTITY PER SECONDARY CONTAINER | STRIP 10 |
| CRLK | PRIMARY CONTAINER CONTENT QUANTITY | TABLETS 21.000 |
| CSCW | TOTAL PRIMARY CONTAINER QUANTITY | 10 |
| AKJA | ACTIVE MEDICAMENT MEDICINAL STRENGTH | MILLIGRAMS PYRIDOSTIGMINE BROMIDE ACTIVE INGREDIENT 30.000 |
| CBBL | FEATURES PROVIDED | INDIVIDUALLY SEALED |